Recalcitrant pemphigus successfully treated with lenalidomide

This is a preview of subscription content, log in to check access.


  1. 1.

    Hertl M, Jedlickova H, Karpati S, et al. Pemphigus. S2 Guideline for diagnosis and treatment-guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2015; 29: 405614.

    Article  Google Scholar 

  2. 2.

    Kotla V, Goel S, Nischal S, et al. Mechanism of action of lenalido-mide in hematological malignancies. J Hematol Oncol 2009; 2: 36.

    Article  Google Scholar 

  3. 3.

    Masjedi M, Esmaeil N, Saffaei A, et al. Cytokine indexes in pemphigus vulgaris: perception of its immunpathogenesis and hopes for non-steroidal treatment. Iran J Pharm Res 2017; 16: 122369.

    Google Scholar 

  4. 4.

    Caso F, Iaccarino L, Bettio S, et al. Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab. Immunol Res 2013; 56: 39067.

    Article  Google Scholar 

  5. 5.

    Lee F-C. Longterm clinical remission of oral and cutaneous pemphigus with thalidomide. Int J Dermatol 2011; 50: 11206.

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Regina Treudler.

Additional information


Financial support: none. Conflicts of interest: none.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zader, J., Vucinic, V., Simon, J.C. et al. Recalcitrant pemphigus successfully treated with lenalidomide. Eur J Dermatol 30, 178–179 (2020).

Download citation